Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH CML 2022 | Unmet needs in CML: dealing with resistance and progression, pregnancy, QoL & access to treatment

Giora Sharf, Israeli CML Patients Organization, Netanya, Israel, highlights some of the key challenges in the field of chronic myeloid leukemia, including improving quality of life (QoL), dealing with resistance, progression, and toxicity to available therapies, and managing pregnant women with CML. This interview took place at the 24th Annual John Goldman Conference on Chronic Myeloid Leukemia (ESH CML) held in Mandelieu-La Napoule, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Novartis: Advisory Board; BI: Speaker, Abbvie: Advisory Board